Blog

Small modifications in the FY 2021 Index and Tabular have large implications with regard to data and comparative data collection going forward for a common diagnosis, “depression.” NJPR has developed a coding crossword puzzle to help reinforce correct coding. Please download the crossword puzzle below, and submit your completed puzzle via the contact form to […]

Introduction Small modifications in the FY 2021 Index and Tabular have large implications with regard to data and comparative data collection going forward for a common diagnosis, “depression.”  Many coders who transitioned from ICD-9-CM to ICD-10-CM on October 1, 2015, quickly recognized that there was no accurate, unique code in ICD-10-CM that replaced ICD-9-CM code […]

The Goldilocks breast reconstruction procedure is an option that is “just right” for certain women in comparison to other available types of breast reconstruction procedures. The option that is “just right” is influenced by what type of mastectomy was performed, the details of a cancer diagnosis and pending treatments, the patient’s body type and the […]

Introduction A question was posed to the American Hospital Association’s Coding Clinic for ICD-10-CM/ICD-10-PCS Advisory Board, (“CC”) requesting guidance on the correct coding for a bilateral “Goldilocks breast reconstruction.“ The question and response appear in “CC” Volume 8, Number 2, Second Quarter 2021, page 16. “CC” advises that “Coding advice or code assignments contained in […]

Alzheimer’s disease (AD), proposed codes and modifications to the Tabular for reporting dementia, and a new drug, – Aduhelm, recently approved by the FDA to treat Alzheimer’s disease, all result in new coding changes. NJPR has developed a coding crossword puzzle to help reinforce correct coding. Please download the crossword puzzle below, and submit your […]

Background In this blog we discuss Alzheimer’s disease (AD), proposed codes and modifications to the Tabular for reporting dementia, and a new drug, – Aduhelm, recently approved by the FDA to treat Alzheimer’s disease.  Increased attention to and a renewed focus on treatments for Alzheimer ’s disease (AD) occurred when the Food and Drug Administration […]